USP Launches Initiative to Fight Counterfeit Drugs in Sub-Saharan Africa
FDA Issues Pharmacoepidemiologic Safety Study Guidance
Global Biosimilars Market to Reach $2.445 Billion in 2013
Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators
First Biologic Approved in the EU for Gouty Arthritis
Roche and BioLamina Collaborate on Novel Cell Culture Systems
Modulating the innate immune response by combinatorial engineering of endotoxin
Toll-like receptor 4 stimulation improves Alzheimer’s disease-related pathology
Lonza Expands Antibody-Drug Conjugate Manufacturing Capacity
JMC NC, Inc. | 2530 Meridian Parkway, 3rd Floor | Durham, NC 27713 USA | Phone: +1 (919) 484-7555 | Fax: +1 (919) 484-7644
© JMC NC, INC. All rights reserved. | Website design by Web Symphonies.